Clinical Trials
57 trialsMultidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
PeriPharm
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
National Institutes of Health Clinical Center (CC)
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
START
Lyell Immunopharma, Inc.
SCC-BAREDU
University of Oklahoma
HPVAC2
University Hospital, Brest
HRCC1
Azienda Policlinico Umberto I
EXCYTE-1
Exscientia AI Limited
ECOvar
Stiftung Swiss Tumor Institute
Long Term Survivors in Ovarian Cancer
University Medical Center Groningen
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
Wake Forest University Health Sciences
Confocal
British Columbia Cancer Agency
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
British Columbia Cancer Agency
SGO Society of Gynecologic Oncologists Data Outcomes Project
University of New Mexico
OVA360
Aspira Women's Health
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
University Health Network, Toronto
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
University of Washington
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
British Columbia Cancer Agency
Effect of PARP Inhibitors on Glomerular Filtration Rate
University of Pennsylvania
HPVAC
University Hospital, Brest
HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
Puma Biotechnology, Inc.
CRONUS
AstraZeneca
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Abramson Cancer Center at Penn Medicine
Natera Ovarian Cancer Detection Assay
Natera, Inc.
The Role of Hypoxia as a Selective Pressure for TP53 Mutations
Institute of Cancer Research, United Kingdom
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients
M.D. Anderson Cancer Center
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans
National Institutes of Health Clinical Center (CC)
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
N1
CureOne
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Vanderbilt-Ingram Cancer Center
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
GOG Foundation
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
Mayo Clinic
Racial Disparity in Endometrial Cancer
University of Louisville
Cervical Cancer Screening Project Part C
University of Minnesota
SUIVICOL
University Hospital, Bordeaux
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Virginia Commonwealth University
Sexual Functioning After Primary Treatment of Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
UNC Lineberger Comprehensive Cancer Center
Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation
Gynesonics
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Minnesota
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
University of Arkansas
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
GOG Foundation
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Precision Therapeutics
ChemoFx® PRO - A Post-Market Data Collection Study
Precision Therapeutics
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics